These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2231169)

  • 1. [Epidermal growth factor in cholesteatoma--the second report: the localization in the horny layer].
    Goto Y
    Nihon Jibiinkoka Gakkai Kaiho; 1990 Aug; 93(8):1192-9. PubMed ID: 2231169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidermal growth factor in cholesteatoma--the first report: the localization in the cholesteatoma tissue].
    Goto Y
    Nihon Jibiinkoka Gakkai Kaiho; 1990 Aug; 93(8):1186-91. PubMed ID: 2231168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of filaggrin in human middle ear cholesteatoma.
    Chao WY; Huang CC
    Acta Otolaryngol; 1989; 107(3-4):249-53. PubMed ID: 2648749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor expression in middle ear cholesteatoma.
    Chi HP; Ho KY; Chai CY; Ta CF; Wang LF; Lee KW; Kuo WR; Wu SC; Tsai SM
    Kaohsiung J Med Sci; 2004 Jan; 20(1):6-11. PubMed ID: 15481560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and localization of mRNA for epidermal growth factor and epidermal growth factor receptor in human cholesteatoma.
    Kojima H; Shiwa M; Kamide Y; Moriyama H
    Acta Otolaryngol; 1994 Jul; 114(4):423-9. PubMed ID: 7976315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokeratin expression in cholesteatoma matrix, meatal epidermis and middle ear epithelium. A preliminary report.
    van Blitterswijk CA; Grote JJ
    Acta Otolaryngol; 1988; 105(5-6):529-32. PubMed ID: 2456666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of involucrin in human middle ear cholesteatoma.
    Chao WY; Huang CC
    Am J Otol; 1989 Sep; 10(5):385-8. PubMed ID: 2683803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of S100A1 in external auditory canal cholesteatoma.
    Naim R; Hormann K
    Oncol Rep; 2006 Oct; 16(4):671-5. PubMed ID: 16969478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of epidermal growth factor receptor in human middle ear cholesteatoma.
    Hsu YC; Ho KY; Chai CY; Lee KW; Wang LF; Wu SC; Kuo WR; Tsai SM
    Kaohsiung J Med Sci; 2003 Oct; 19(10):497-502. PubMed ID: 14620675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the epidermal growth factor system in human middle ear cholesteatoma.
    Thorup MB; Munk M; Poulsen SS; Gaihede M; Nexo E; Sorensen BS; Ovesen T
    Acta Otolaryngol; 2014 Feb; 134(2):124-34. PubMed ID: 24256036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of epidermal growth factor receptor in aural cholesteatoma.
    Bujía J; Holly A; Schilling V; Negri B; Pitzke P; Schulz P
    Laryngoscope; 1993 Mar; 103(3):326-9. PubMed ID: 7680089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokeratins in induced epidermoid formations and cholesteatoma lesions.
    Vennix PP; Kuijpers W; Tonnaer EL; Peters TA; Ramaekers FC
    Arch Otolaryngol Head Neck Surg; 1990 May; 116(5):560-5. PubMed ID: 1691647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expressions of isopeptide bonds and corneodesmosin in middle ear cholesteatoma.
    Koizumi H; Kawaguchi R; Ohkubo JI; Ikezaki S; Kitamura T; Hohchi N; Hashida K; Suzuki H
    Clin Otolaryngol; 2017 Apr; 42(2):252-262. PubMed ID: 27390311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.
    Xie S; Wang X; Ren H; Liu X; Ren J; Liu W
    Acta Otolaryngol; 2017 Aug; 137(8):797-802. PubMed ID: 28498080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of fibronectin in human middle ear cholesteatoma.
    Chao WY; Yuan QG; Huang CC
    Arch Otorhinolaryngol; 1988; 245(3):160-5. PubMed ID: 3052388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen expression of epithelial markers, collagen IV and Ki67 in middle ear cholesteatoma. An immunohistochemical Study.
    Ergün S; Zheng X; Carlsöö B
    Acta Otolaryngol; 1994 May; 114(3):295-302. PubMed ID: 7521107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma: an analysis of protein production and gene expression.
    Bujía J; Kim C; Holly A; Sudhoff H; Ostos P; Kastenbauer E
    Am J Otol; 1996 Mar; 17(2):203-6. PubMed ID: 8723947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphotoxin in human middle ear cholesteatoma.
    Yan SD; Huang CC
    Laryngoscope; 1991 Apr; 101(4 Pt 1):411-5. PubMed ID: 1680210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokeratin patterns of tissues related to cholesteatoma pathogenesis.
    Van Blitterswijk CA; Grote JJ; Lutgert RW; Hesseling SC; Out CJ; Van Muijen GN; Fransen JA
    Ann Otol Rhinol Laryngol; 1989 Aug; 98(8 Pt 1):635-40. PubMed ID: 2475048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohistochemical study of the epithelial hyperproliferation in middle ear cholesteatoma].
    Li H; Jiang P; Wang L
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):118-20. PubMed ID: 12768722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.